Enrolling By Invitation NA INTERVENTIONAL 2-arm
NCT07415811
Spironolactone and XPB-1 Integrity in the TFIIH Complex (SPIRIT-XPB)
Evaluation of the Impact of Spironolactone Use on the Integrity of the XPB-1 Subunit of the TFIIH Complex In Vivo
Sponsor: The Scripps Research Institute
Conditions
HIV
Interventions
Spironolactone (drug)
Updated 1 time since 2026 Last updated: Feb 9, 2026 Started: Jul 24, 2024 Primary completion: Dec 11, 2024 Completion: Jul 1, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This NA trial investigates HIV and is currently ongoing. The Scripps Research Institute leads this study, which shows 1 recorded version since 2024 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
1 version recorded Enrolling By Invitation — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- The Scripps Research Institute
- University of Sao Paulo General Hospital
Data source: University of Sao Paulo General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .